Amedisys recognized as top investment pick by Fortune magazine

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health nursing companies, today announced that Fortune magazine named Amedisys on its list of the 10 Best Stocks for 2010 in its issue dated December 21, 2009.

“with an aging population ever more in need of its services, Amedisys seems poised to thrive, and its shares should recover, no matter what happens in Congress.”

The article states that Amedisys has had a 32%-a-year earnings growth over the past five years. They further write that “with an aging population ever more in need of its services, Amedisys seems poised to thrive, and its shares should recover, no matter what happens in Congress.”

“We are pleased to be recognized as a top investment pick by Fortune magazine. The guiding principles of our company are to provide superior clinical service to our patients, grow our business aggressively and become as operationally efficient as possible which gives us a strategic advantage in growing both our home health and hospice divisions and will allow us to evolve into a premiere post acute care complex chronic care provider,” stated William F. Borne, Chief Executive Officer of Amedisys, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into brain aging and Alzheimer's from non-human primates